New PCT: Nucleic acid therapy for differential modulation of host microflora Agnes April 26, 2022 News March 2022 – WO 2022/070052 A1, a new PCT covering the effect of our IBD-asset on gut dysbiosis and impaired barrier function, was published online. You Might Also Like Drug Mechanism of Action demonstrated: Mucosal healing without immune suppression April 26, 2022 CCFI /Région Auvergne Rhône-Alpes April 13, 2021 ECCO 2022 April 26, 2022